DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition

The overall prognosis for pancreatic cancer remains dismal and potent chemotherapeutic agents that selectively target this cancer are critically needed. Elevated expression of NAD(P)H:quinone oxidoreductase 1 (NQO1) is frequent in pancreatic cancer, and it offers promising tumor-selective targeting....

Descripción completa

Detalles Bibliográficos
Autores principales: Viera, Talysa, Patidar, Praveen L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677541/
https://www.ncbi.nlm.nih.gov/pubmed/33214574
http://dx.doi.org/10.1038/s41598-020-76850-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677541/
https://www.ncbi.nlm.nih.gov/pubmed/33214574
http://dx.doi.org/10.1038/s41598-020-76850-4

Ejemplares similares